Antibody Conjugates for Sarcoma Therapy: How Far along Are We?

Sarcomas are one of the most difficult type of cancer to manage and treat because of their extremely heterogeneous molecular and morphological features. Despite the progress made over the years in the establishment of standard protocols for high and low grading/staging sarcoma patients, mostly with...

Descripción completa

Detalles Bibliográficos
Autores principales: Polito, Letizia, Calafato, Giulia, Bortolotti, Massimo, Chiarelli Olivari, Cecilia, Maiello, Stefania, Bolognesi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392509/
https://www.ncbi.nlm.nih.gov/pubmed/34440182
http://dx.doi.org/10.3390/biomedicines9080978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392509/
https://www.ncbi.nlm.nih.gov/pubmed/34440182
http://dx.doi.org/10.3390/biomedicines9080978

Ejemplares similares